Listener feedback on the PROGRESS trial, the first Factor XI inhibitor improved, left bundle branch pacing, and statin discontinuation in older adults are the topics John Mandrola, MD, discusses in this week’s podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: I Listener Feedback PROGRESS Trial https://www.nejm.org/doi/abs/10.1056/NEJMoa2607326 II FDA Approves Asundexian in Stroke Will FDA-Approved Factor XIa Change Secondary Stroke Prevention? https://www.medscape.com/viewarticle/will-fda-approved-factor-xia-change-secondary-stroke-2026a100177u OCEANIC-STROKE Trial https://www.nejm.org/doi/10.1056/NEJMoa2513880 Bleeding With Asundexian vs Placebo in Patients With Ischemic Stroke or High-Risk TIA https://pubmed.ncbi.nlm.nih.gov/42866879/ OCEANIC-AF trial https://www.nejm.org/doi/full/10.1056/NEJMoa2407105 III Another Weak Pacing RCT – OptimPacing The Best Pacing Strategy for AV Block: A Head vs Heart Analysis of The O
The moderate aortic stenosis TAVR trial, blinded withdrawal in the DECISION digoxin trial, CTO-PCI vs no CTO-PCI 10-year results, and the P4 trial are the topics John Mandrola, MD, discusses in this week’s podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: I PROGRESS Trial PROGRESS Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2607326 PROGRESS Trial Editorial https://www.nejm.org/doi/full/10.1056/NEJMe2613400 Genereux Classification https://academic.oup.com/eurheartj/article/38/45/3351/4002776 II Withdrawing Digoxin in the DECISION trial DECISION Trial Substudy https://academic.oup.com/eurheartj/article/47/38/5545/8674856 DECISION Trial - Main Trial https://www.nature.com/articles/s41591-026-04406-6 Efficacy and Safety of Digitalis Glycosides in HF: Meta-analysis https://jamanetwork.com/journals/jama/fullarticle/2848972 RADIANCE trial https://www.nejm.org/doi/full/10.1056/NEJM199307013290101 PROVED trial https://w